Finance

Lists
002294:SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
၃၀.၈၄ CN¥
+၀.၈၅%
(+၀.၂၆) 1D
အောက် ၁၆, GMT+၈ ၁၅:၀၄:၅၄  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002294...
Open
၃၀.၈၃ CN¥
High
၃၁.၈၀ CN¥
Low
၃၀.၈၂ CN¥
Mkt. cap
ဋေ ၃.၄၄ ထ
Avg. vol.
၉.၅၅ သန်း
Volume
၂.၇၉ ကုဋေ
Dividend
၁.၇၈%
Quarterly dividend
၀.၁၄ CN¥
Ex-dividend date
၂၀၂၆ မေ ၂၆
P/E ratio
၅၁.၀၅
52-wk high
၇၀.၉၉ CN¥
52-wk low
၂၉.၂၅ CN¥
EPS
၀.၆၀ CN¥
Shares outstanding
၁၁၁.၄၈ ဋေ
No. of employees
၄ ထောင်
Open
၃၀.၈၃ CN¥
High
၃၁.၈၀ CN¥
Low
၃၀.၈၂ CN¥
Mkt. cap
ဋေ ၃.၄၄ ထ
Avg. vol.
၉.၅၅ သန်း
Volume
၂.၇၉ ကုဋေ
Dividend
၁.၇၈%
Quarterly dividend
၀.၁၄ CN¥
Ex-dividend date
၂၀၂၆ မေ ၂၆
P/E ratio
၅၁.၀၅
52-wk high
၇၀.၉၉ CN¥
52-wk low
၂၉.၂၅ CN¥
EPS
၀.၆၀ CN¥
Shares outstanding
၁၁၁.၄၈ ဋေ
No. of employees
၄ ထောင်
News stories
From web sources and news partners
tech-insider.org
tech-insider.org
·
ပြီးခဲ့သည့် ၁ နာရီ
Trump Calls AI Warnings ‘HOAX’, Nasdaq Drops 0.9% [2026]
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၁ ရက်
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၁ ရက်
Stock Market Ends Week With Software Sell-Off; Nasdaq Dives 2%, Gives Up 200-Day Line
Profile
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019. Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
About Shenzhen Salubris Pharmaceuticals Co Ltd
CEO-
Employees၄.၀၉ ထောင်
Founded၁၉၉၈ နို ၃
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁၁၁.၀၃ ဋေ
၁၁၁.၁၄ ဋေ
၁၂၂.၈၄ ဋေ
၁၂၅.၀၇ ဋေ
Cost of goods sold
၂၇.၉၃ ကုဋေ
၃၀.၂၉ ကုဋေ
၂၈.၇၇ ကုဋေ
၃၄.၃၂ ကုဋေ
Cost of revenue
၂၇.၉၃ ကုဋေ
၃၀.၂၉ ကုဋေ
၂၈.၇၇ ကုဋေ
၃၄.၃၂ ကုဋေ
Research and development expenses
၁၂.၇၆ ကုဋေ
၁၇.၆၄ ကုဋေ
၁၃.၁၃ ကုဋေ
၁၃.၉၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄၈.၆၈ ကုဋေ
၅၆.၈၃ ကုဋေ
၅၅.၁၆ ကုဋေ
၅၉.၆၇ ကုဋေ
Operating expense
၅၉.၅၇ ကုဋေ
၇၇.၀၁ ကုဋေ
၆၉.၄၄ ကုဋေ
၇၄.၉၂ ကုဋေ
Total operating expenses
၈၇.၅၀ ကုဋေ
၁၀၇.၃၀ ဋေ
၉၈.၂၀ ကုဋေ
၁၀၉.၂၄ ဋေ
Operating income
၂၃.၅၄ ကုဋေ
၃.၈၄ ကုဋေ
၂၄.၆၄ ကုဋေ
၁၅.၈၃ ကုဋေ
Other non operating income
-၁.၄၆ ကုဋေ
၁.၃၈ ကုဋေ
-၅.၂၇ သန်း
၅.၄၀ သန်း
EBT including unusual items
၂၃.၄၁ ကုဋေ
၅.၂၁ သန်း
၂၅.၅၅ ကုဋေ
၁၄.၂၄ ကုဋေ
EBT excluding unusual items
၂၄.၆၂ ကုဋေ
၇.၂၀ ကုဋေ
၂၅.၂၀ ကုဋေ
၁၆.၁၀ ကုဋေ
Income tax expense
၁.၈၁ ကုဋေ
-၅.၆၂ ကုဋေ
၂.၉၆ ကုဋေ
-၂.၂၃ ကုဋေ
Effective tax rate
၇.၇၂%
-၁,၀၇၈.၄၈%
၁၁.၆၀%
-၁၅.၆၅%
Other operating expenses
-၁.၇၈ ကုဋေ
၃.၄၁ ကုဋေ
၉.၆၁ သန်း
၁.၆၃ ကုဋေ
Net income
၂၁.၅၆ ကုဋေ
၇.၀၈ ကုဋေ
၂၂.၅၃ ကုဋေ
၁၆.၁၈ ကုဋေ
Net profit margin
၁၉.၄၂%
၆.၃၇%
၁၈.၃၄%
၁၂.၉၄%
Earnings per share
-
-
-
-
Interest and investment income
၂.၆၉ ကုဋေ
၃.၇၈ ကုဋေ
၁.၅၀ ကုဋေ
၁.၂၃ ကုဋေ
Interest expense
-၄.၈၈ သန်း
-၇.၅၀ သန်း
-၄.၁၇ သန်း
-၄.၉၇ သန်း
Net interest expenses
၂.၂၀ ကုဋေ
၃.၀၃ ကုဋေ
၁.၀၉ ကုဋေ
၇.၃၂ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၃၂.၅၅ ကုဋေ
၁၃.၅၅ ကုဋေ
၃၄.၃၅ ကုဋေ
၂၅.၇၉ ကုဋေ
Gain or loss from assets sale
-၉.၈၄ သိန်း
၃.၀၃ သန်း
-
၁.၆၆ သိန်း
AI content may include mistakes. Learn more
Google အက်ပ်များ